pharmaphorum

Novartis adds another string to iptacopan’s bow

Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by disorders of the complement ...
pharmaphorum

Novo Nordisk looks set to add another string to Ozempic bow

Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...
BBC

Another string to your bow

Jiaying This is The English We Speak from BBC Learning English and we’re talking about the phrase ‘another string to your bow’ which describes having an additional skill to use if the first skill ...